Among the creation of geomorphological maps the data collection of elements and features is one of the most important steps. The most relevant information to be collected are not only their position ...(geolocalization) but also their classification and properties according to the official encoding: within this context the Italian National Geologic Service (SGN) set up data collection and data storing standards through a focused documentation, the “I Quaderni” (series III), n.4 e n.10. In this paper we describe a new system to collect these kind of data directly on the field through the most commonly used tablets and smartphones. This system is based on an ESRI Geodatabase Enterprise installed on a server, an ArcGIS Online account and the ESRI Collector App for smartphones. Data collected by operators on the field are directly sent to the Geodatabase on server using mobile internet connection; data structure and format follow the national standards, so they are ready to be added into a geomorphological map.
Among the creation of geomorphological maps the data collection of elements and features is one of the most important steps. The most relevant information to be collected are not only their position ...(geolocalization) but also their classification and properties according to the official encoding: within this context the Italian National Geologic Service (SGN) set up data collection and data storing standards through a focused documentation, the “I Quaderni” (series III), n.4 e n.10. In this paper we describe a new system to collect these kind of data directly on the field through the most commonly used tablets and smartphones. This system is based on an ESRI Geodatabase Enterprise installed on a server, an ArcGIS Online account and the ESRI Collector App for smartphones. Data collected by operators on the field are directly sent to the Geodatabase on server using mobile internet connection; data structure and format follow the national standards, so they are ready to be added into a geomorphological map.
Among the Civil Protection plan creation the data collection of buildings and infrastructures is one of the most important step. The most relevant information to be collected are not only their ...position (geolocalization) but also their Civil Protection functionalities and peculiarities. Within this context Lombardy Region set up data collection and data storing standards through a focused law. In this paper we describe a new system to collect these kind of data directly on the field. This system is based on an ESRI Geodatabase Enterprise installed on a server, an ArcGIS Online account and the ESRI Collector App for smartphones. Data collected by operators on the field are directly sent to the Geodatabase on server using mobile internet connection; data structure and format follow Lombardy Region standards and they are ready to be loaded on the official Civil Protection Planning platform.
Among the Civil Protection plan creation the data collection of buildings and infrastructures is one of the most important step. The most relevant information to be collected are not only their ...position (geolocalization) but also their Civil Protection functionalities and peculiarities. Within this context Lombardy Region set up data collection and data storing standards through a focused law. In this paper we describe a new system to collect these kind of data directly on the field. This system is based on an ESRI Geodatabase Enterprise installed on a server, an ArcGIS Online account and the ESRI Collector App for smartphones. Data collected by operators on the field are directly sent to the Geodatabase on server using mobile internet connection; data structure and format follow Lombardy Region standards and they are ready to be loaded on the official Civil Protection Planning platform.
Preliminary data have shown the Firebird™ and the Cypher® stents have similar safety and efficacy profiles. However, to date, no study has evaluated the percutaneous coronary intervention (PCI) with ...the Firebird™ stent in diabetic patients.
The performance of the Firebird™ stent in diabetic patients with multivessel coronary artery disease (CAD) (n=100) was compared to that of the Cypher® stent, using historical data from the ARTS-II study (n=159). We compared the major adverse cardiovascular events (MACE) at one year.
Most of the patients in the Firebird™ group were male (65%), with mean age of 63.3±10.4years and 5% were receiving insulin. Stable coronary syndromes were prevalent (60%), 45% had three-vessel CAD and ventricular function was preserved (56.6±13.7%). In patients with three-vessel CAD, 135 lesions were treated with≥3 stents in 78% of the cases and 2 stents in the remaining ones. In patients with two-vessel CAD, 110 lesions were treated with≥2 stents in 80% of the cases and 1 stent in the remaining ones. The incidence of MACE at one year of the Firebird™ stent was 21%, death was observed in 3% of the patients, myocardial infarction in 2% and a new revascularization procedure in 18%, predominantly at the expense of a new PCI in 14% of the cases. Comparison with the Cypher® group did not show differences for any of the evaluated endpoints.
In our study, the use of the Firebird™ stent showed similar results to those of patients in the ARTS-II study, which makes it attractive for use in the complex scenario of diabetic patients with multivessel CAD.
Desempenho do Stent Farmacológico Firebird™ em DiabéticosPortadores de Doença Coronária Multiarterial
Dados preliminares têm demonstrado que o perfil de segurança e eficácia do stent Firebird™ é semelhante ao do stent Cypher®. No entanto, até o presente momento, nenhum estudo avaliou a intervenção coronária percutânea (ICP) com o Firebird™ em diabéticos.
Comparamos, em diabéticos portadores de doença arterial coronária (DAC) multiarterial, o desempenho do Firebird™ (n = 100) ao do Cypher®, utilizando os dados históricos do estudo ARTS-II (n = 159). Foram comparados os eventos cardiovasculares adversos maiores (ECAM) em um ano.
A maioria dos pacientes do grupo Firebird™ era do sexo masculino (65%), com média de idade de 63,3 ± 10,4 anos e 5% estavam em uso de insulina. Predominaram os quadros clínicos estáveis (60%), 45% eram portadores de DAC triarterial e a função ventricular era preservada (56,6 ± 13,7%). Nos pacientes com DAC triarterial, foram tratadas 135 lesões, com 3 ou mais stents em 78% dos casos e 2 stents nos demais. Nos pacientes com DAC biarterial, foram tratadas 110 lesões com 2 ou mais stents em 80% dos casos e 1 stent nos demais. A incidência de ECAM em um ano do Firebird™ foi de 21%, óbito ocorreu em 3% dos pacientes, infarto do miocárdio em 2%, e novo procedimento de revascularização miocárdica em 18%, predominantemente à custa de nova ICP em 14% dos casos. A comparação com o grupo Cypher® não mostrou diferenças para nenhum dos desfechos avaliados.
Em nosso estudo, o uso do stent Firebird™ apresentou resultados similares aos dos pacientes do estudo ARTS-II, o que o torna atrativo para ser utilizado no complexo cenário de pacientes diabéticos portadores de DAC multiarterial.
Preliminary data have shown the Firebird™ and the Cypher® stents have similar safety and efficacy profiles. However, to date, no study has evaluated the percutaneous coronary intervention (PCI) with ...the Firebird™ stent in diabetic patients.
The performance of the Firebird™ stent in diabetic patients with multivessel coronary artery disease (CAD) (n=100) was compared to that of the Cypher® stent, using historical data from the ARTS-II study (n=159). We compared the major adverse cardiovascular events (MACE) at one year.
Most of the patients in the Firebird™ group were male (65%), with mean age of 63.3±10.4years and 5% were receiving insulin. Stable coronary syndromes were prevalent (60%), 45% had three-vessel CAD and ventricular function was preserved (56.6±13.7%). In patients with three-vessel CAD, 135 lesions were treated with≥3 stents in 78% of the cases and 2 stents in the remaining ones. In patients with two-vessel CAD, 110 lesions were treated with≥2 stents in 80% of the cases and 1 stent in the remaining ones. The incidence of MACE at one year of the Firebird™ stent was 21%, death was observed in 3% of the patients, myocardial infarction in 2% and a new revascularization procedure in 18%, predominantly at the expense of a new PCI in 14% of the cases. Comparison with the Cypher® group did not show differences for any of the evaluated endpoints.
In our study, the use of the Firebird™ stent showed similar results to those of patients in the ARTS-II study, which makes it attractive for use in the complex scenario of diabetic patients with multivessel CAD.
Desempenho do Stent Farmacológico Firebird™ em Diabéticos Portadores de Doença Coronária Multiarterial
Dados preliminares têm demonstrado que o perfil de segurança e eficácia do stent Firebird™ é semelhante ao do stent Cypher®. No entanto, até o presente momento, nenhum estudo avaliou a intervenção coronária percutânea (ICP) com o Firebird™ em diabéticos.
Comparamos, em diabéticos portadores de doença arterial coronária (DAC) multiarterial, o desempenho do Firebird™ (n = 100) ao do Cypher®, utilizando os dados históricos do estudo ARTS-II (n = 159). Foram comparados os eventos cardiovasculares adversos maiores (ECAM) em um ano.
A maioria dos pacientes do grupo Firebird™ era do sexo masculino (65%), com média de idade de 63,3 ± 10,4 anos e 5% estavam em uso de insulina. Predominaram os quadros clínicos estáveis (60%), 45% eram portadores de DAC triarterial e a função ventricular era preservada (56,6 ± 13,7%). Nos pacientes com DAC triarterial, foram tratadas 135 lesões, com 3 ou mais stents em 78% dos casos e 2 stents nos demais. Nos pacientes com DAC biarterial, foram tratadas 110 lesões com 2 ou mais stents em 80% dos casos e 1 stent nos demais. A incidência de ECAM em um ano do Firebird™ foi de 21%, óbito ocorreu em 3% dos pacientes, infarto do miocárdio em 2%, e novo procedimento de revascularização miocárdica em 18%, predominantemente à custa de nova ICP em 14% dos casos. A comparação com o grupo Cypher® não mostrou diferenças para nenhum dos desfechos avaliados.
Em nosso estudo, o uso do stent Firebird™ apresentou resultados similares aos dos pacientes do estudo ARTS-II, o que o torna atrativo para ser utilizado no complexo cenário de pacientes diabéticos portadores de DAC multiarterial.
PDF
